Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHL
11451
DELISTED
Achilles Therapeutics
ACHL
| $63.2K | ﹤0.01% |
66,843
-403
| -0.6% | -$383 |
|
11452
TELA Bio
TELA
$28.9M
| $63.1K | ﹤0.01% |
6,230
-26,846
| -81% | -$275K |
|
11453
PUT
Resources Connection
RGP
$145M
| $62.8K | ﹤0.01% |
4,000
-1,300
| -25% | -$20.2K |
|
11454
CALL
Regis Corp
RGS
$69.3M
| $62.8K | ﹤0.01% |
2,830
-555
| -16% | -$11.9K |
|
11455
PUT
Syndax Pharmaceuticals
SNDX
$1.77B
| $62.8K | ﹤0.01% |
3,000
-13,000
| -81% | -$271K |
|
11456
PUT
Sabesp
SBS
$16.2B
| $62.8K | ﹤0.01% |
27,330
-169,649
| -86% | -$340K |
|
11457
CALL
CAE Inc
CAE
$8.43B
| $62.7K | ﹤0.01% |
2,800
-3,500
| -56% | -$77.5K |
|
|
11458
PUT
CAE Inc
CAE
$8.43B
| $62.7K | ﹤0.01% |
2,800
+1,900
| +211% | +$42.1K |
|
|
AKTS
11459
PUT
DELISTED
Akoustis Technologies Inc
AKTS
| $62.3K | ﹤0.01% |
19,600
-16,100
| -45% | -$49.4K |
|
11460
CALL
Amtech Systems
ASYS
$281M
| $62.1K | ﹤0.01% |
6,500
+2,600
| +67% | +$23.6K |
|
11461
CEL-SCI Corp
CVM
$26.9M
| $62.1K | ﹤0.01% |
+859
| New | +$62.5K |
|
11462
PUT
Lifestance Health
LFST
$4.75B
| $62.1K | ﹤0.01% |
6,800
-4,500
| -40% | -$37.4K |
|
|
KW
11463
PUT
DELISTED
Kennedy-Wilson Holdings
KW
| $62.1K | ﹤0.01% |
3,800
+900
| +31% | +$14.4K |
|
11464
Adicet Bio
ACET
$78.4M
| $62K | ﹤0.01% |
1,595
-17,966
| -92% | -$1.59M |
|
11465
PUT
KRONOS Worldwide
KRO
$975M
| $62K | ﹤0.01% |
7,100
+2,100
| +42% | +$18.5K |
|
11466
PUT
Star Holdings Shares of Beneficial Interest
STHO
$118M
| $61.9K | ﹤0.01% |
+4,220
| New | +$66.8K |
|
|
KLRS
11467
CALL
Kalaris Therapeutics
KLRS
$97.1M
| $61.9K | ﹤0.01% |
791
-931
| -54% | -$88.5K |
|
|
PRSU
11468
CALL
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $61.8K | ﹤0.01% |
2,300
+1,200
| +109% | +$26.7K |
|
11469
CALL
RAVE Restaurant Group
RAVE
$43.2M
| $61.8K | ﹤0.01% |
30,600
-2,800
| -8% | -$4.64K |
|
11470
CALL
Franklin Electric
FELE
$4.68B
| $61.7K | ﹤0.01% |
+600
| New | +$56.3K |
|
|
11471
PUT
Franklin Electric
FELE
$4.68B
| $61.7K | ﹤0.01% |
+600
| New | +$56.3K |
|
11472
CALL
Katapult Holdings
KPLT
$36.7M
| $61.7K | ﹤0.01% |
2,744
+464
| +20% | +$7.02K |
|
11473
CALL
WisdomTree
WT
$3.46B
| $61.7K | ﹤0.01% |
9,000
-26,800
| -75% | -$179K |
|
11474
ClearOne Inc
CLRO
$14M
| $61.7K | ﹤0.01% |
4,971
-278
| -5% | -$5.85K |
|
11475
CALL
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$20.3B
| $61.7K | ﹤0.01% |
300
-9,100
| -97% | -$1.76M |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.